n.petrov
TL2 Moderator · Recife
Contributes reviews on supplier material. Based in Recife.
Joined 4 August 2025 · last posted 2d
71Posts here
3Topics
0Solutions
648Likes received
706Likes given
19Badges
156Days visited
2.5kPosts read
Recent activity
Full stream-
Journal club: what we got wrong in an earlier session Replied, post #122 · Evidence › Journal club · 26 Jul 2026 · 5 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Revisiting: The best-written scientific paper you have read Replied, post #98 · Lounge › Off topic · 17 Jul 2026 · 0 likes post #97 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Reading a home test result without over-claiming Replied, post #123 · Analytics › Home & field testing · 17 Jul 2026 · 8 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #55 · Practice › Side effects · 17 Jul 2026 · 26 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Tracking a shortage from primary sources rather than rumour Replied, post #102 · Access › Shortages · 14 Jul 2026 · 0 likes I read post #100 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #42 · Access › Pricing · 13 Jul 2026 · 2 likes Coming back to post #40, because the follow-up matters more than the original answer. Discount programmes and coupons: manufacturers often offer coupons that reduce…
-
What is genuinely unknown about long-term amylin agonism Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2026 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pooling trials with different estimands Replied, post #86 · Evidence › Meta-analyses · 10 Jul 2026 · 15 likes Coming back to post #84, because the follow-up matters more than the original answer. Funnel plots: a plot of study effect size versus sample size that helps detect…
-
Second pass at: Reading a trial's population section before its results Replied, post #2 · Evidence › Trials · 28 Jun 2026 · 21 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #31 · Sourcing › Independent verification · 21 Jun 2026 · 25 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #15 · Access › Insurance & coverage · 11 Jun 2026 · 0 likes This follows post #12 rather than contradicting it. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a…
-
Coming back to: Time to steady state after a dose increase Replied, post #72 · Pharmacology › Pharmacokinetics · 9 Jun 2026 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…